Radu Razvan Scurtu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Radu Razvan Scurtu has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Catalin C. Ciuce
First Surgical Clinic, Emergency County University Hospital, 400347 Cluj-Napoca, Romania
2 shared publications Radu Drasovean
Iuliu Hatieganu Univ Med & Pharm, Dept Surg, 8 Victor Babes St, Cluj Napoca 400001, Romania
2 shared publications- Raluca Cristina Ailioaie
Department of Surgery, Iuliu Hatieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania
2 shared publications Raluca Cristina Apostu
Iuliu Hatieganu Univ Med & Pharm, Dept Surg, 8 Victor Babes St, Cluj Napoca 400001, Romania
2 shared publications- Vlad Fagarasan
Department of Surgery, Iuliu Hatieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania
2 shared publications - Alexandra Maria Boldis
First Surgical Clinic, Clinical Emergency County Hospital, 3-5 Clinicilor Street, 400347 Cluj-Napoca, Romania
1 shared publication
Latest Publications
- Open Access
- 17 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (20) , 8080
Obesity in the 21st Century: Where Do We Stand?
Obesity in the 21st century has become a global epidemic owing to its heterogeneous aetiology and clinical presentation, as well as the development of associated comorbidities such as cardiovascular disease, type2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, and obesity-related cancers. Notably, cardiovascular disease and diabetes are major contributors to obesity-associated morbidity and mortality. Current diagnostic approaches rely predominantly on anthropometric measurements, which have proven limited in their ability to provide accurate and clinically meaningful stratification of patients with obesity. Consequently, obesity treatments, including metabolic surgery and pharmacological therapies, remain insufficiently tailored to the wide variability in obesity-related genotypes, phenotypes, and endotypes. In this context, a personalised medical approach offers considerable promise. A clear overview of currently effective diagnostic tools and treatments, as well as future possibilities, is therefore needed. Recent developments in precision medicine, multi-omics, biomarkers, and advanced diagnostic technologies may facilitate improved patient stratification and support more individualized therapeutic strategies. Together, these approaches may contribute to a more comprehensive, evidence-based, and patient-centered framework for the prevention, diagnosis, and management of obesity and its complications.
- 17 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (20) , 8080
Open AccessObesity in the 21st Century: Where Do We Stand?
Obesity in the 21st century has become a global epidemic owing to its heterogeneous aetiology and clinical presentation, as well as the development of associated comorbidities such as cardiovascular disease, type2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, and obesity-related cancers. Notably, cardiovascular disease and diabetes are major contributors to obesity-associated morbidity and mortality. Current diagnostic approaches rely predominantly on anthropometric measurements, which have proven limited in their ability to provide accurate and clinically meaningful stratification of patients with obesity. Consequently, obesity treatments, including metabolic surgery and pharmacological therapies, remain insufficiently tailored to the wide variability in obesity-related genotypes, phenotypes, and endotypes. In this context, a personalised medical approach offers considerable promise. A clear overview of currently effective diagnostic tools and treatments, as well as future possibilities, is therefore needed. Recent developments in precision medicine, multi-omics, biomarkers, and advanced diagnostic technologies may facilitate improved patient stratification and support more individualized therapeutic strategies. Together, these approaches may contribute to a more comprehensive, evidence-based, and patient-centered framework for the prevention, diagnosis, and management of obesity and its complications.
- Open Access
- 28 April 2026
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 40 (3) , 1452-1462
Association of Transforming Growth Factor-β1 and α-Smooth Muscle Actin in Experimental Selective Obstructive Cholestasis
Hepatic bile duct obstruction is a common cause of cholestasis. In cases of persistent obstruction, fibrosis and cirrhosis occur. A detailed analysis of fibrogenesis will allow the treatment for this condition to be refined and outcomes to be improved. We assessed the induction of fibrosis in selective obstructive cholestasis by determining the expression of alpha-smooth muscle actin (α-SMA) and transforming growth factor beta 1 (TGF-β1). Selective bile duct ligation of two of four hepatic lobes was performed in rats. α-SMA and TGF-β1 expression was assessed at 30 days by immunohistochemistry, and hepatic fibrosis was quantified. The expression levels of the two markers were graded and compared, while the correlation with fibrosis was tested. Descriptive and inferential statistical tests were performed. At 30 days, a pre-fibrotic stage was reached. Marker expression was identified in both obstructed and unobstructed parenchyma, with higher expression in the obstructed tissue. TGF-β1 had a more intense expression, and α-SMA expression was significantly correlated with fibrosis. Ito cells showed the highest level of expression. Fibrogenesis appears to be initiated in all liver parenchyma early after the induction of cholestasis. α-SMA expression is highly correlated with the degree of fibrosis. A long-term evaluation of the model should be performed for better characterization.
- 28 April 2026
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 40 (3) , 1452-1462
Open AccessAssociation of Transforming Growth Factor-β1 and α-Smooth Muscle Actin in Experimental Selective Obstructive Cholestasis
Hepatic bile duct obstruction is a common cause of cholestasis. In cases of persistent obstruction, fibrosis and cirrhosis occur. A detailed analysis of fibrogenesis will allow the treatment for this condition to be refined and outcomes to be improved. We assessed the induction of fibrosis in selective obstructive cholestasis by determining the expression of alpha-smooth muscle actin (α-SMA) and transforming growth factor beta 1 (TGF-β1). Selective bile duct ligation of two of four hepatic lobes was performed in rats. α-SMA and TGF-β1 expression was assessed at 30 days by immunohistochemistry, and hepatic fibrosis was quantified. The expression levels of the two markers were graded and compared, while the correlation with fibrosis was tested. Descriptive and inferential statistical tests were performed. At 30 days, a pre-fibrotic stage was reached. Marker expression was identified in both obstructed and unobstructed parenchyma, with higher expression in the obstructed tissue. TGF-β1 had a more intense expression, and α-SMA expression was significantly correlated with fibrosis. Ito cells showed the highest level of expression. Fibrogenesis appears to be initiated in all liver parenchyma early after the induction of cholestasis. α-SMA expression is highly correlated with the degree of fibrosis. A long-term evaluation of the model should be performed for better characterization.
- Open Access
- 23 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (9) , 3226
Rare Appendicular Pathologies: Diagnostic Challenges, Surgical Management, and Outcomes in a Retrospective Tertiary-Center Cohort with Literature Review
Background: Rare appendicular pathologies (RAP) are uncommon clinical entities with important diagnostic and therapeutic implications. These conditions frequently mimic acute appendicitis, yet they may require different operative strategies and, in selected cases, oncological management. Methods: We performed a retrospective cohort study including all patients who underwent surgery with the intention of performing an appendectomy at the First Surgical Clinic, Emergency County University Hospital of Cluj-Napoca, between 2018 and 2021. During this interval, 330 appendectomies were performed. Patients with a histopathological diagnosis of RAP were included. Clinical, imaging, surgical, histopathological, postoperative, and follow-up data were analyzed, with particular attention to the preoperative diagnostic work-up and imaging-based suspicion of rare appendicular pathology. Results: Ten patients (3.03%) were diagnosed with RAP, including low-grade appendiceal mucinous neoplasm (LAMN; n = 5), mucinous cystadenoma (n = 2), appendiceal adenocarcinoma (n = 1), appendicular diverticulum (n = 1), and stump appendicitis (n = 1). Computed tomography was the main diagnostic modality, particularly in patients with atypical presentation or suspicion of complicated or neoplastic appendiceal disease, while magnetic resonance imaging and colonoscopy provided additional information in selected cases. Preoperative suspicion of a rare or neoplastic appendiceal pathology was achieved in 70% of patients. Laparoscopic appendectomy was performed in 6 patients, open appendectomy in 1 patient, open ileocecal resection in 1 patient, open right hemicolectomy in 1 patient, and laparoscopic right hemicolectomy in 1 patient. Histopathological examination confirmed the diagnosis in all cases. Immediate postoperative outcomes were favorable, without perioperative mortality or major complications; during follow-up, the patient with adenocarcinoma required oncological treatment and resection of a local recurrence 1 year after surgery. Conclusions: RAP represent a small but clinically significant subset of appendiceal disease. Structured preoperative imaging, intraoperative recognition of atypical findings, and an individualized surgical strategy are essential for optimal outcomes and appropriate oncological management.
- 23 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (9) , 3226
Open AccessRare Appendicular Pathologies: Diagnostic Challenges, Surgical Management, and Outcomes in a Retrospective Tertiary-Center Cohort with Literature Review
Background: Rare appendicular pathologies (RAP) are uncommon clinical entities with important diagnostic and therapeutic implications. These conditions frequently mimic acute appendicitis, yet they may require different operative strategies and, in selected cases, oncological management. Methods: We performed a retrospective cohort study including all patients who underwent surgery with the intention of performing an appendectomy at the First Surgical Clinic, Emergency County University Hospital of Cluj-Napoca, between 2018 and 2021. During this interval, 330 appendectomies were performed. Patients with a histopathological diagnosis of RAP were included. Clinical, imaging, surgical, histopathological, postoperative, and follow-up data were analyzed, with particular attention to the preoperative diagnostic work-up and imaging-based suspicion of rare appendicular pathology. Results: Ten patients (3.03%) were diagnosed with RAP, including low-grade appendiceal mucinous neoplasm (LAMN; n = 5), mucinous cystadenoma (n = 2), appendiceal adenocarcinoma (n = 1), appendicular diverticulum (n = 1), and stump appendicitis (n = 1). Computed tomography was the main diagnostic modality, particularly in patients with atypical presentation or suspicion of complicated or neoplastic appendiceal disease, while magnetic resonance imaging and colonoscopy provided additional information in selected cases. Preoperative suspicion of a rare or neoplastic appendiceal pathology was achieved in 70% of patients. Laparoscopic appendectomy was performed in 6 patients, open appendectomy in 1 patient, open ileocecal resection in 1 patient, open right hemicolectomy in 1 patient, and laparoscopic right hemicolectomy in 1 patient. Histopathological examination confirmed the diagnosis in all cases. Immediate postoperative outcomes were favorable, without perioperative mortality or major complications; during follow-up, the patient with adenocarcinoma required oncological treatment and resection of a local recurrence 1 year after surgery. Conclusions: RAP represent a small but clinically significant subset of appendiceal disease. Structured preoperative imaging, intraoperative recognition of atypical findings, and an individualized surgical strategy are essential for optimal outcomes and appropriate oncological management.
- Open Access
The Influence of Analgesic Wound Infiltration on Postoperative Pain and Inflammatory Cytokines in Open Colorectal Surgery: A Randomized Comparative Pilot Study
Background and Objectives: Surgical wound analgesia has been analyzed in many studies, but few have focused on its relationship with inflammatory markers. As such, we aimed to determine the influence of analgesic surgical wound infiltration in open colorectal surgery on the seric levels of pro- and anti-inflammatory markers and the associated efficacy in postoperative pain control. Materials and Methods: Forty patients who underwent open colorectal surgery were prospectively randomized: group 0, epidural analgesia; group 1, intravenous analgesia (control), group 2, preincision and prelaparoraphy infiltration; and, group 3, prelaparoraphy infiltration. Wound infiltration was performed with ropivacaine. We analyzed the levels of IL-6 and IL-10 cytokines before and 6 h after surgery and their correlation with pain scores. Results: The postoperative Il-6 levels were significantly lower in group 0 than in the control (p = 0.041). The postoperative Il-10 levels were significantly higher in group 3 (p = 0.029) than in the control. Six hours after the operation, the pain scores were significantly lower in all groups than in the control (p = 0.005, p = 0.022, and p = 0.017 for groups 0, 2, and 3, respectively). Pain scores were significantly correlated with Il-10 levels in group 2 (p = 0.047); in group 3, IL-10 levels directly correlated with those of Il-6 (p = 0.026). Conclusions: The analgetic effect of preincisional and prelaparoraphy analgetic infiltration was efficient. The analgetic infiltration of the surgical wound prior to closure stimulates both the inflammatory activator and regulator interleukins.
Open AccessThe Influence of Analgesic Wound Infiltration on Postoperative Pain and Inflammatory Cytokines in Open Colorectal Surgery: A Randomized Comparative Pilot Study
Background and Objectives: Surgical wound analgesia has been analyzed in many studies, but few have focused on its relationship with inflammatory markers. As such, we aimed to determine the influence of analgesic surgical wound infiltration in open colorectal surgery on the seric levels of pro- and anti-inflammatory markers and the associated efficacy in postoperative pain control. Materials and Methods: Forty patients who underwent open colorectal surgery were prospectively randomized: group 0, epidural analgesia; group 1, intravenous analgesia (control), group 2, preincision and prelaparoraphy infiltration; and, group 3, prelaparoraphy infiltration. Wound infiltration was performed with ropivacaine. We analyzed the levels of IL-6 and IL-10 cytokines before and 6 h after surgery and their correlation with pain scores. Results: The postoperative Il-6 levels were significantly lower in group 0 than in the control (p = 0.041). The postoperative Il-10 levels were significantly higher in group 3 (p = 0.029) than in the control. Six hours after the operation, the pain scores were significantly lower in all groups than in the control (p = 0.005, p = 0.022, and p = 0.017 for groups 0, 2, and 3, respectively). Pain scores were significantly correlated with Il-10 levels in group 2 (p = 0.047); in group 3, IL-10 levels directly correlated with those of Il-6 (p = 0.026). Conclusions: The analgetic effect of preincisional and prelaparoraphy analgetic infiltration was efficient. The analgetic infiltration of the surgical wound prior to closure stimulates both the inflammatory activator and regulator interleukins.
- Open Access
- 16 February 2022
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 10 (5) , 1654-1666
Wilkie’s syndrome as a cause of anxiety-depressive disorder: A case report and review of literature
Superior mesenteric artery syndrome is a disease with a complex diagnosis, and it is associated with complications that make it even harder to identify. Currently, a frequent association with psychiatric disorders has been noted. Despite numerous case reports and case series, the variability of the disease has not allowed the development of protocols regarding diagnosis and management. A 33-year-old woman presented with abdominal pain, nausea, and bile vomiting over the last 15 mo, associated with a 15-kg weight loss over the last three months. After the onset of the symptoms, the patient was diagnosed with anxiety-depressive disorder and treated appropriately. Standard examinations excluded an organic cause, and the cause of the symptoms was considered psychogenic. The persistence of symptoms, even under treatment, prompted a computer tomography angiography examination of the abdomen and pelvis. The examination identified emergence at a sharp angle of 13.7° of the superior mesenteric artery, with a reduced distance between the artery and the anterior wall of the aorta up to a maximum of 8 mm. A diagnosis of aortomesenteric clamp was established. Surgical treatment by laparoscopic duodenojejunostomy was performed. Postoperative evolution was marked by a patent anastomosis at 1 mo, with a 10-kg weight gain and improvement of the associated anxiety. This case report underlines two major aspects. One aspect refers to the predisposition of patients with superior mesenteric artery syndrome to develop psychiatric disorders, with an excellent outcome when proper treatment is administered. The second aspect underlines the key role of a multidisciplinary approach and follow-up.
- 16 February 2022
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 10 (5) , 1654-1666
Open AccessWilkie’s syndrome as a cause of anxiety-depressive disorder: A case report and review of literature
Superior mesenteric artery syndrome is a disease with a complex diagnosis, and it is associated with complications that make it even harder to identify. Currently, a frequent association with psychiatric disorders has been noted. Despite numerous case reports and case series, the variability of the disease has not allowed the development of protocols regarding diagnosis and management. A 33-year-old woman presented with abdominal pain, nausea, and bile vomiting over the last 15 mo, associated with a 15-kg weight loss over the last three months. After the onset of the symptoms, the patient was diagnosed with anxiety-depressive disorder and treated appropriately. Standard examinations excluded an organic cause, and the cause of the symptoms was considered psychogenic. The persistence of symptoms, even under treatment, prompted a computer tomography angiography examination of the abdomen and pelvis. The examination identified emergence at a sharp angle of 13.7° of the superior mesenteric artery, with a reduced distance between the artery and the anterior wall of the aorta up to a maximum of 8 mm. A diagnosis of aortomesenteric clamp was established. Surgical treatment by laparoscopic duodenojejunostomy was performed. Postoperative evolution was marked by a patent anastomosis at 1 mo, with a 10-kg weight gain and improvement of the associated anxiety. This case report underlines two major aspects. One aspect refers to the predisposition of patients with superior mesenteric artery syndrome to develop psychiatric disorders, with an excellent outcome when proper treatment is administered. The second aspect underlines the key role of a multidisciplinary approach and follow-up.
- Open Access
- 26 December 2021
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 9 (36) , 11369-11381
Difficulties in diagnosing anorectal melanoma: A case report and review of the literature
Anorectal melanoma is a tumour that is difficult to identify due to its rarity and variability of presentation. Insufficient data published in the literature do not allow for diagnostic and treatment guidelines to be established. Anorectal melanoma has the worst prognosis among mucosal melanomas and is frequently misdiagnosed by standard identification methods. A 66-year-old woman presented with intermittent anal bleeding, pain, and tenesmus in the past month, with no associated weight loss. Colonoscopy revealed a cauliflower-like tumour with a diameter of 1.5 cm, with exulcerated areas and an adherent clot but without obstruction. Biopsy results identified an inflammatory rectal polyp with nonspecific chronic rectitis. Tumour markers CA 19-9 and CEA were within the normal range. After 6 mo, due to the persistence of symptoms, a pelvic magnetic resonance imaging scan was performed. A lesion measuring 2.8 cm × 2.7 cm × 2.1 cm was identified at the anorectal junction, along with two adjacent lymphadenopathies. No distant metastases were detected. Immunohistochemistry was performed on the second set of biopsies, and a diagnosis of anorectal melanoma was established. Surgical treatment by abdominoperineal resection was performed. Evolution was marked by the appearance of lung metastases at 1 mo postoperatively, detected on a positron emission tomography-computer tomography scan, and perineal recurrence after 5 mo. After molecular testing, the patient was included in an immunotherapy trial. This case highlights the difficulty of establishing a definitive early diagnosis of anorectal melanoma, the importance of performing histological analysis on a well-represented biopsy specimen, and the poor prognosis, even with radical surgery.
- 26 December 2021
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 9 (36) , 11369-11381
Open AccessDifficulties in diagnosing anorectal melanoma: A case report and review of the literature
Anorectal melanoma is a tumour that is difficult to identify due to its rarity and variability of presentation. Insufficient data published in the literature do not allow for diagnostic and treatment guidelines to be established. Anorectal melanoma has the worst prognosis among mucosal melanomas and is frequently misdiagnosed by standard identification methods. A 66-year-old woman presented with intermittent anal bleeding, pain, and tenesmus in the past month, with no associated weight loss. Colonoscopy revealed a cauliflower-like tumour with a diameter of 1.5 cm, with exulcerated areas and an adherent clot but without obstruction. Biopsy results identified an inflammatory rectal polyp with nonspecific chronic rectitis. Tumour markers CA 19-9 and CEA were within the normal range. After 6 mo, due to the persistence of symptoms, a pelvic magnetic resonance imaging scan was performed. A lesion measuring 2.8 cm × 2.7 cm × 2.1 cm was identified at the anorectal junction, along with two adjacent lymphadenopathies. No distant metastases were detected. Immunohistochemistry was performed on the second set of biopsies, and a diagnosis of anorectal melanoma was established. Surgical treatment by abdominoperineal resection was performed. Evolution was marked by the appearance of lung metastases at 1 mo postoperatively, detected on a positron emission tomography-computer tomography scan, and perineal recurrence after 5 mo. After molecular testing, the patient was included in an immunotherapy trial. This case highlights the difficulty of establishing a definitive early diagnosis of anorectal melanoma, the importance of performing histological analysis on a well-represented biopsy specimen, and the poor prognosis, even with radical surgery.
- Open Access
Biological and Histological Assessment of the Hepatoportoenterostomy Role in Biliary Atresia as a Stand-Alone Procedure or as a Bridge toward Liver Transplantation
Background and objectives: In patients with biliary atresia (BA), hepatoportoenterostomy (HPE) is still a valuable therapeutic tool for prolonged survival or a safer transition to liver transplantation. The main focus today is towards efficient screening programs, a faster diagnostic, and prompt treatment. However, the limited information on BA pathophysiology makes valuable any experience in disease management. This study aimed to analyze the evolution and survival of patients with BA referred for HPE (Kasai operation) in our department. Materials and Methods: A retrospective analysis was performed on fourteen patients with BA, diagnosed in the pediatric department and further referred for HPE in our surgical department between 2010 and 2016. After HPE, the need for transplantation was assessed according to patients cytomegalovirus (CMV) status, and histological and biochemical analysis. Follow-up results at 1–4 years and long term survival were assessed. Results: Mean age at surgery was 70 days. Surgery in patients younger than 60 days was correlated with survival. Jaundice’s clearance rate at three months was 36%. Total and direct bilirubin values had a significant variation between patients with liver transplants and native liver (p = 0.02). CMV was positive in eight patients, half with transplant need and half with native liver survival. Smooth muscle actin (SMA) positivity was proof of advanced fibrosis. The overall survival rate was 79%, with 75% for native liver patients and an 83% survival rate for those with liver transplantation. Transplantation was performed in six patients (43%), with a mean of 10 months between HPE and transplantation. Transplanted patients had better survival. Complications were diagnosed in 63% of patients. The mean follow-up period was six years. Conclusions: HPE, even performed in advanced cirrhosis, allows a significant survival, and ensures an essential time gain for patients requiring liver transplantation. A younger age at surgery is correlated with a better outcome, despite early CMV infection.
Open AccessBiological and Histological Assessment of the Hepatoportoenterostomy Role in Biliary Atresia as a Stand-Alone Procedure or as a Bridge toward Liver Transplantation
Background and objectives: In patients with biliary atresia (BA), hepatoportoenterostomy (HPE) is still a valuable therapeutic tool for prolonged survival or a safer transition to liver transplantation. The main focus today is towards efficient screening programs, a faster diagnostic, and prompt treatment. However, the limited information on BA pathophysiology makes valuable any experience in disease management. This study aimed to analyze the evolution and survival of patients with BA referred for HPE (Kasai operation) in our department. Materials and Methods: A retrospective analysis was performed on fourteen patients with BA, diagnosed in the pediatric department and further referred for HPE in our surgical department between 2010 and 2016. After HPE, the need for transplantation was assessed according to patients cytomegalovirus (CMV) status, and histological and biochemical analysis. Follow-up results at 1–4 years and long term survival were assessed. Results: Mean age at surgery was 70 days. Surgery in patients younger than 60 days was correlated with survival. Jaundice’s clearance rate at three months was 36%. Total and direct bilirubin values had a significant variation between patients with liver transplants and native liver (p = 0.02). CMV was positive in eight patients, half with transplant need and half with native liver survival. Smooth muscle actin (SMA) positivity was proof of advanced fibrosis. The overall survival rate was 79%, with 75% for native liver patients and an 83% survival rate for those with liver transplantation. Transplantation was performed in six patients (43%), with a mean of 10 months between HPE and transplantation. Transplanted patients had better survival. Complications were diagnosed in 63% of patients. The mean follow-up period was six years. Conclusions: HPE, even performed in advanced cirrhosis, allows a significant survival, and ensures an essential time gain for patients requiring liver transplantation. A younger age at surgery is correlated with a better outcome, despite early CMV infection.